Latest Schedule 13G passive stakes

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen jointly filed a Schedule 13G, reporting beneficial ownership of 6.0% of RxSight, Inc. common stock.

Alta Partners LLC has reported beneficial ownership of 687,321 shares, representing 8.4% of BioVie Inc.'s Class A Common Stock, acquired via warrants.

Nexera Technologies Ltd. has disclosed beneficial ownership of 11,416,863 common shares, representing 72.53% of Fort Technology Inc., with certain restrictions on further acquisition.

Nexera Technologies Ltd. has disclosed beneficial ownership of 11,416,863 common shares, representing 72.53% of Fort Technology Inc., with certain restrictions on further acquisition.

Terry LaCore has filed an amendment to Schedule 13G, confirming beneficial ownership of 159,585 shares of Mannatech Inc. common stock, representing 8.3% of the class.

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed a Schedule 13G, reporting beneficial ownership of 9.9% of Outlook Therapeutics, Inc. common stock.

Terry LaCore has filed an amendment to a Schedule 13G, reporting an 8.27% beneficial ownership of Mannatech Inc. common stock as of June 30, 2026.

H2O America's Schedule 13G filing is amended to correct reporting designations, confirming ATLAS Infrastructure Partners (UK) Ltd. and GIP Atlas Holdings Limited collectively hold 11.03% of common stock.

Imperial Vision Fund SPC Series 1 SP has reported the sale of all its Class A ordinary shares in Dreamland Ltd, reducing its beneficial ownership to zero.

Todd W. Fennell has reported beneficial ownership of approximately 10.2% of Prothena Corp's ordinary shares, primarily through various trusts.

Gores Sponsor XI LLC, AEG Holdings, LLC, and Alec Gores collectively hold a 20.3% stake in Gores Holdings XI, Inc., comprising Class A and convertible Class B shares.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.8% of Tenax Therapeutics, Inc. common stock.

Voss Capital and affiliated entities have reported beneficial ownership of 12,700,000 ordinary shares, representing 5.1% of Cellebrite DI Ltd.'s outstanding stock.

Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, have reported beneficial ownership of 4.99% of Silexion Therapeutics Corp. ordinary shares.

Soleus Capital entities and Guy Levy have filed a joint Schedule 13G statement, reporting beneficial ownership of 5.8% of Processa Pharmaceuticals, Inc. common stock.

PSB Financial, Inc. Employee Stock Ownership Plan Trust reports a beneficial ownership of 137,540 shares, representing 8.0% of the company's common stock as of June 30, 2026.

BJI Financial Group has filed a Schedule 13G, reporting beneficial ownership of 6.85% of C1 Fund Inc.'s common stock as of August 18, 2026.

Taiji Ito has disclosed beneficial ownership of 39,613,355 shares, representing 8.13% of Advasa Holdings, Inc.'s common stock.

Several entities affiliated with Patriot Financial have reported a decrease in their beneficial ownership of CoastalSouth Bancshares, Inc. common stock, now holding less than 5% individually.

First City Investment Group, LLC has disclosed beneficial ownership of 37,153 shares, representing 2.0% of Generation Income Properties, Inc.'s common stock.

Clear Street Derivatives LLC has reported beneficial ownership of 3,550,631 shares, representing 5.71% of Kartoon Studios Inc.'s common stock, as of June 30, 2026.

Clearthink Capital Partners, LLC has filed a Schedule 13G, disclosing beneficial ownership of 9.9% of Edgemode, Inc.'s common stock.

Seah Chia Yee has reported beneficial ownership of 146,539 shares, representing 10.3% of Addentax Group Corp.'s common stock, as of August 11, 2026.

David Bogart has filed a Schedule 13G, reporting beneficial ownership of 2,293,750 shares, representing 8.1% of Conexeu Sciences Inc.'s common stock.

An amendment to a Schedule 13G filing for BrightSpire Capital, Inc. corrects a reporting entity's name and reaffirms beneficial ownership of 8.6% of Class A Common Stock.

Esousa Group Holdings LLC and Michael Wachs have reported beneficial ownership of 821,469 ordinary shares, representing 9.9% of VCI Global Ltd, subject to a beneficial ownership limitation.

Esousa Group Holdings LLC and Michael Wachs have disclosed a beneficial ownership of 9.9% in VivoSim Labs, Inc. common stock, totaling 319,429 shares, as of June 30, 2026.

Joseph H. Moglia and associated entities report a combined beneficial ownership of 7.8% of FG Nexus Inc. common stock as of August 17, 2026.

Logos Global Management LP and affiliated entities have reported beneficial ownership of 9.99% of Achieve Life Sciences, Inc. common stock, primarily through managed funds and options.

Fenelon Opportunity Fund Inc., The Gregory Fenelon Revocable Living Trust, and Gregory Fenelon collectively report beneficial ownership of 5.0% of Hyatt Hotels Corp. common stock.